Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 6, 2008, Pages 1227-1233

  Domelier, Anne Sophie ^a,b   van der Mee Marquet, Nathalie ^a,b   Arnault, Laurence ^b   Mereghetti, Laurent ^a   Lanotte, Philippe ^a   Rosenau, Agnès ^a   Lartigue, Marie Frédérique ^a,b   Quentin, Roland ^a,b  

^a UNIVERSITÉ DE TOURS   (France)

^b SERVICE DE DERMATOLOGIE   (France)

Author keywords

Group B streptococcus; Infectious diseases; Macrolide; Molecular markers; Resistance genes; Virulence

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; CLINDAMYCIN; DNA FRAGMENT; ERYTHROMYCIN; PROTEIN ERM A; PROTEIN ERM B; PROTEIN MEF A; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE SEQUENCE; GENITAL TRACT INFECTION; HUMAN; INTRON; MENINGITIS; NEWBORN; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; STOMACH JUICE; STREPTOCOCCUS AGALACTIAE;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; DNA FINGERPRINTING; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ERYTHROMYCIN; FEMALE; GASTRIC JUICE; GENES, BACTERIAL; GENOTYPE; HUMANS; INFANT, NEWBORN; INTRONS; LINCOSAMIDES; MENINGITIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; STREPTOGRAMIN B; VAGINA;

EID: 56649123526     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn388     Document Type: Article

References (34)

1. Schuchat A. Epidemiology of group B streptococcal disease in the United States: Shifting paradigms. Clin Microbiol Rev 1998; 11: 497-513.
2. Borchardt SM, DeBusscher JH, Tallman PA et al. Frequency of antimicrobial resistance among invasive and colonizing group B Streptococcal isolates. BMC Infect Dis 2006; 6: 57-64.
3. Fluegge K, Supper S, Siedler A et al. Serotype distribution of invasive group B streptococcal isolates in infants: Results from a nationwide active laboratory surveillance study over 2 years in Germany. Clin Infect Dis 2005; 40: 760-3.
4. Schoening TE, Wagner J, Arvand M. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany. Clin Microbiol Infect 2005; 11: 579-82.
5. Weisner AM, Johnson AP, Lamagni TL et al. Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis 2004; 38: 1203-8.
6. Agence nationale d'Accréditation en Santé. Antenatal Prevention of the Risk of Early Neonatal Bacterial Infection, 2001. http://www.has-sante.fr/portail/upload/docs/application/pdf/ Antenatal_prevention.pdf (28 March 2008, date last accessed).
7. Schrag SJ, Gorwitz R, Fultz-Butts K et al. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002; 51: 1-22.
8. Betriu C, Culebras E, Gómez M et al. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob Agents Chemother 2003; 47: 1112-4.
9. Klaassen CHW, Mouton JW. Molecular detection of the macrolide efflux gene: To discriminate or not to discriminate between mef(A) and mef(E). Antimicrob Agents Chemother 2005; 49: 1271-8.
10. Roberts MC, Sutcliffe J, Courvalin P et al. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 1999; 43: 2823-30.
11. Loulergue J, Couhé C, Grasmick C et al. Sensibilité aux antibiotiques des souches de streptocoque du groupe B de portage vaginal isolées en France, 2003. BEH 2004; 18: 69-70.
12. Quentin R, Loulergue J, Mala L et al. Group B streptococcus as human pathogen: Origin of isolates and antibiotic susceptibility. BEH 2006; 45: 352-4.
13. Doran KS, Nizet V. Molecular pathogenesis of neonatal group B streptococcal infection: No longer in its infancy. Mol Microbiol 2004; 54: 23-31.
14. Héry-Arnaud G, Bruant G, Lanotte P et al. Acquisition of insertion sequences and the GBSi1 intron by Streptococcus agalactiae isolates correlates with the evolution of the species. J Bacteriol 2005; 187: 6248-52.
15. Jones N, Bohnsack JF, Takahashi S et al. Multilocus sequence typing system for group B streptococcus. J Clin Microbiol 2003; 41: 2530-6.
16. Quentin R, Huet H, Wang FS et al. Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: Identification of multiple virulent clone families that cause invasive neonatal disease. J Clin Microbiol 1995; 33: 2576-81.
17. Bidet P, Brahimi N, Chalas C et al. Molecular characterization of serotype III group B-Streptococcus isolates causing neonatal meningitis. J Infect Dis 2003; 188: 1132-7.
18. Granlund M, Michel F, Norgren M. Mutually exclusive distribution of IS 1548 and GBSi1, an active group II intron identified in human isolates of group B streptococci. J Bacteriol 2001; 183: 2560-9.
19. van der Mee-Marquet N, Domelier AS, Mereghetti L et al. Prophagic DNA fragments in Streptococcus agalactiae strains and association with neonatal meningitis. J Clin Microbiol 2006; 44: 1049-58.
20. Rolland K, Marois C, Siquier V et al. Genetic features of Streptococcus agalactiae strains causing neonatal infections, as revealed by pulsed-field gel electrophoresis and hylB gene analysis. J Clin Microbiol 1999; 37: 1892-8.
21. Lin FY, Whiting A, Adderson E et al. Phylogenetic lineages of invasive and colonizing strains of serotype III group B streptococci from neonates: A multicenter prospective study. J Clin Microbiol 2006; 44: 1257-61.
22. Kong F, Gowan S, Martin D et al. Serotype identification of group B streptococci by PCR and sequencing. J Clin Microbiol 2002; 40 216-26.
23. Rosenau A, Martins K, Amor S et al. Evaluation of the ability of S. agalactiae strains isolated from genital and neonatal specimens to bind to human fibrinogen and correlation with characteristics of the fbsA and fbsB genes. Infect Immun 2007; 75: 1310-7.
24. Members of the SFM Antibiogram Committee. Comité de l'Antibiogramme de la Société Française de Microbiologie report 2003. Int J Antimicrob Agents 2003; 21: 364-91.
25. de Azavedo JCS, McGavin M, Duncan C et al. Prevalence and mechanisms of macrolide resistance in invasive and non-invasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 2001; 45: 3504-8.
26. Poyart C, Jardy L, Quesne G et al. Genetic basis resistance of Streptococcus agalactiae strains isolated in a French hospital. Antimicrob Agents Chemother 2003; 47: 794-77.
27. Lamy MC, Dramsi S, Billoêt A et al. Rapid detection of the 'highly virulent' group B streptococcus ST-17 clone. Microbes Infect 2006; 8: 1714-22.
28. Dogan B, Schukken YH, Santisteban C et al. Distribution of serotypes and antimicrobial resistance genes among Streptococcus agalactiae isolates from bovine and human hosts. J Clin Microbiol 2005; 43: 5899-906.
29. Uh Y, Kim HY, Jang IH et al. Correlation of serotypes and geno-types of macrolide-resistant Streptococcus agalactiae. Yonsei Med J 2005; 46: 480-3.
30. Gherardi G, Imperi M, Baldassarri L et al. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J Clin Microbiol 2007; 45: 2909-16.
31. Marimón JM, Valiente A, Ercibengoa M et al. Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae. Antimicrob Agents Chemother 2005; 49: 5069-74.
32. Puopolo KM, Klinzing DC, Lin MP et al. A composite transposon associated with erythromycin and clindamycin resistance in group B streptococcus. J Med Microbiol 2007; 56: 947-55.
33. Pallen MJ, Wren BW. Bacterial pathogenomics. Nature 2007; 449 835-42.
34. Schoen C, Blom J, Claus H et al. Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis. Proc Natl Acad Sci USA 2008; 105: 3473-8.